Similarly, in patients with colorectal cancer, the novel marker Plastin3 identified the most aggressive CTCs undergoing EMT in one-third of 711 patients with colorectal cancers [11]; these Plastin3-positive CTCs showed inducible staining of the EMT marker vimentin. This evidence concerns the gene VIM and colorectal cancer.